Patent Assignment
Reel/Frame 039431/0976
Assignment of Assignor's Interest
Recorded: 2016-08-15
Pages: 8
Assignors
BUKHALID, RAGHIDA
Executed: 2012-06-12
NIELSEN, ULRIK
Executed: 2012-06-12
WERNER, SHANNON
Executed: 2012-06-12
KEARNS, JEFFREY DAVID
Executed: 2012-06-13
Assignee
MERRIMACK PHARMACEUTICALS, INC.
ONE KENDALL SQUARE, SUITE B7201, CAMBRIDGE, MASSACHUSETTS, 02139
Covered Property
(1)
Monoclonal and Oligoclonal Anti-Egfr Antibodies for Use in the Treatment of Tumors Expressing Predominantly High Affinity Egfr Ligands or Tumors Expressing Predominantly Low Affinity Egfr Ligands
Application:
15/234,402 →